{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:23:32Z","timestamp":1789439012303,"version":"build-2803163510"},"reference-count":280,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01488","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T08:43:03Z","timestamp":1545208983000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular Complications"],"prefix":"10.3389","volume":"9","author":[{"given":"Monica","family":"de Gaetano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Cacace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Godson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.113.004390","article-title":"Athero-prone flow activation of the SREBP2-NLRP3 inflammasome mediates focal atherosclerosis.","volume":"128","author":"Abe","year":"2013","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(07)61696-1","article-title":"The burden and costs of chronic diseases in low-income and middle-income countries.","volume":"370","author":"Abegunde","year":"2007","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.37","article-title":"The genetics of diabetic complications.","volume":"11","author":"Ahlqvist","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1111\/bph.12724","article-title":"Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.","volume":"171","author":"Ali","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.113.005015","article-title":"Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.","volume":"129","author":"Allahverdian","year":"2014","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2337\/dc08-2064","article-title":"Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.","volume":"32","author":"Angiolillo","year":"2009","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","first-page":"22847","DOI":"10.1074\/jbc.M603766200","article-title":"Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions.","volume":"281","author":"Arita","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.4049\/jimmunol.178.6.3912","article-title":"Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation.","volume":"178","author":"Arita","year":"2007","journal-title":"J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","article-title":"The human heart contains distinct macrophage subsets with divergent origins and functions.","volume":"24","author":"Bajpai","year":"2018","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.4049\/jimmunol.0803175","article-title":"Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells.","volume":"182","author":"Baker","year":"2009","journal-title":"J. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s12325-014-0140-x","article-title":"Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights.","volume":"31","author":"Baltzis","year":"2014","journal-title":"Adv. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins.","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/dom.12354","article-title":"Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.","volume":"16","author":"Bannister","year":"2014","journal-title":"Diabetes. Obes. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","article-title":"Global overview of the epidemiology of atherosclerotic cardiovascular disease.","volume":"46","author":"Barquera","year":"2015","journal-title":"Arch. Med. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4093\/dmj.2011.35.2.101","article-title":"The causes and consequences of low levels of high density lipoproteins in patients with diabetes.","volume":"35","author":"Barter","year":"2011","journal-title":"Diabetes Metab J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation.","volume":"16","author":"Basil","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.plefa.2017.08.007","article-title":"Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.","volume":"125","author":"Bazan","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1750-3639.2005.tb00513.x","article-title":"Neuroprotectin D1 (n.d.): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.","volume":"15","author":"Bazan","year":"2005","journal-title":"Brain Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.","volume":"34","author":"Beckman","year":"2013","journal-title":"Eur. Heart J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury.","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24690","DOI":"10.1074\/jbc.M112.377101","article-title":"Annexin A1 interaction with the FPR2\/ALX receptor: identification of distinct domains and downstream associated signaling.","volume":"287","author":"Bena","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2337\/db08-1328","article-title":"Enhanced expression of JAK-STAT pathway members in human diabetic nephropathy.","volume":"58","author":"Berthier","year":"2008","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1096\/fj.06-7918com","article-title":"Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing.","volume":"21","author":"Biteman","year":"2007","journal-title":"FASEB J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","article-title":"Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective.","volume":"60","author":"Bongarzone","year":"2017","journal-title":"J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1440-1681.2011.05487.x","article-title":"Chronic kidney disease growth factors in renal fibrosis.","volume":"38","author":"Boor","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1096\/fj.11-185017","article-title":"Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis.","volume":"25","author":"Borgeson","year":"2011","journal-title":"FASEB J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2015.05.003","article-title":"Lipoxin A4 attenuates obesity-induced adipose inflammation and associated liver and kidney disease.","volume":"22","author":"Borgeson","year":"2015","journal-title":"Cell Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1096\/fj.12-208249","article-title":"Lipoxin A4 attenuates adipose inflammation.","volume":"26","author":"Borgeson","year":"2012","journal-title":"FASEB J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis.","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab."},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcb.2014.12.004","article-title":"BMP signalling: agony and antagony in the family.","volume":"25","author":"Brazil","year":"2015","journal-title":"Trends Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.2337\/db16-1405","article-title":"Protective effect of let-7 miRNA family in regulating inflammation in diabetes-associated atherosclerosis.","volume":"66","author":"Brennan","year":"2017","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mam.2017.05.001","article-title":"Specialized pro-resolving mediators in renal fibrosis.","volume":"58","author":"Brennan","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.2337\/db17-1317","article-title":"Lipoxins protect against inflammation in diabetes-associated atherosclerosis.","volume":"67","author":"Brennan","year":"","journal-title":"Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease.","volume":"29","author":"Brennan","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1681\/ASN.2012060550","article-title":"Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1.","volume":"24","author":"Brennan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tem.2008.07.002","article-title":"The many intersecting pathways underlying apolipoprotein B secretion and degradation.","volume":"19","author":"Brodsky","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00002","article-title":"Eating the dead to keep atherosclerosis at bay.","volume":"4","author":"Brophy","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI200524531","article-title":"Gestational diabetes mellitus.","volume":"115","author":"Buchanan","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1681\/ASN.2018020138","article-title":"Cellular origin and functional relevance of collagen I production in the kidney.","volume":"29","author":"Buchtler","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2014.02.009","article-title":"Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.","volume":"40","author":"Buckley","year":"2014","journal-title":"Immunity"},{"key":"B42","first-page":"181","article-title":"Lipoxins: nature\u2019s way to resolve inflammation.","volume":"8","author":"Chandrasekharan","year":"2015","journal-title":"J. Inflamm. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000486398","article-title":"Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study.","volume":"47","author":"Chin","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1159\/000362906","article-title":"Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl.","volume":"39","author":"Chin","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","article-title":"Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARG and LXR\u03b1 pathways.","volume":"108","author":"Chinetti-Gbaguidi","year":"2011","journal-title":"Circ. Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/BF03401642","article-title":"Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation.","volume":"2","author":"Claria","year":"1996","journal-title":"Mol. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"25372","DOI":"10.1074\/jbc.M002863200","article-title":"Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase\/leukotriene B4 12-hydroxydehydrogenase in inflammation.","volume":"275","author":"Clish","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1172\/JCI116601","article-title":"Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.","volume":"92","author":"Colgan","year":"1993","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.11.1767","article-title":"Aspirin therapy in diabetes.","volume":"20","author":"Colwell","year":"1997","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States.","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"B52","first-page":"S54","article-title":"Endothelial dysfunction in diabetes mellitus.","author":"Cosentino","year":"1998","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/labinvest.3700215","article-title":"The role of shear stress in the pathogenesis of atherosclerosis.","volume":"85","author":"Cunningham","year":"2005","journal-title":"Lab. Invest."},{"key":"B54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mam.2017.03.007","article-title":"Does promoting resolution instead of inhibiting inflammation represent the new paradigm in treating infections?","volume":"58","author":"Dalli","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2012.02.003","article-title":"Lipoxins, resolvins, and protectins in the prevention and treatment of diabetic macular edema and retinopathy.","volume":"29","author":"Das","year":"2013","journal-title":"Nutrition"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00275","article-title":"M1- and M2-type macrophage responses are predictive of adverse outcomes in human atherosclerosis.","volume":"7","author":"de Gaetano","year":"2016","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.304164","article-title":"mir33 inhibition overcomes deleterious effects of diabetes on atherosclerosis plaque regression in mice.","volume":"115","author":"Distel","year":"2014","journal-title":"Circ. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1113\/expphysiol.2014.078790","article-title":"Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease.","volume":"99","author":"Docherty","year":"2014","journal-title":"Exp. Physiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj\/eye\/6700095","article-title":"Comparison of serum NO, TNF-alpha, IL-1\u03b2, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.","volume":"16","author":"Doganay","year":"2002","journal-title":"Eye"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.09.002","article-title":"Pro-resolving lipid mediators: agents of anti-ageing?","author":"Doyle","year":"2018","journal-title":"Semin Immunol"},{"key":"B61","author":"Duffield","year":"2010","journal-title":"Macrophages and Immunologic Inflammation of the Kidney. Seminars in Nephrology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis.","volume":"124","author":"Duffield","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B63","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.4049\/jimmunol.177.9.5902","article-title":"Resolvin D series and protectin D1 mitigate acute kidney injury.","volume":"177","author":"Duffield","year":"2006","journal-title":"J. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.atherosclerosis.2018.03.012","article-title":"Native and myeloperoxidase-oxidized low-density lipoproteins act in synergy to induce release of resolvin-D1 from endothelial cells.","volume":"272","author":"Dufour","year":"2018","journal-title":"Atherosclerosis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30129-3","article-title":"Novel diabetes subgroups.","volume":"6","author":"Dutta","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1681\/ASN.2006070704","article-title":"Chronic kidney disease progression.","volume":"17","author":"Eddy","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/01.CIR.13.4.489","article-title":"A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis.","volume":"13","author":"Engelberg","year":"1956","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","article-title":"Origin and functions of tissue macrophages.","volume":"41","author":"Epelman","year":"2014","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes.","volume":"71","author":"Everett","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"i30","DOI":"10.1093\/ndt\/gft430","article-title":"A perspective on anti-CCN2 therapy for chronic kidney disease.","author":"Falke","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"B73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12079-016-0358-2","article-title":"CCN2 reduction mediates protective effects of BMP7 treatment in obstructive nephropathy.","volume":"11","author":"Falke","year":"2017","journal-title":"J. Cell Commun. Signal."},{"key":"B74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.","volume":"95","author":"Fallon","year":"1997","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.110.984146","article-title":"Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.","volume":"123","author":"Feig","year":"2011","journal-title":"Circulation"},{"key":"B76","first-page":"232","article-title":"The role of a murine transplantation model of atherosclerosis regression in drug discovery.","volume":"10","author":"Feig","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"B77","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/wound.2011.0307","article-title":"Regulation of macrophage polarization and wound healing.","volume":"1","author":"Ferrante","year":"2012","journal-title":"Adv. Wound Care"},{"key":"B78","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1590\/S0100-879X2001000500002","article-title":"Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.","volume":"34","author":"Fierro","year":"2001","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/ATVBAHA.115.301926","article-title":"Regression of atherosclerosis: the journey from the liver to the plaque and back.","volume":"36","author":"Fisher","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.jacc.2008.10.031","article-title":"Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (stop atherosclerosis in native diabetics study) trial.","volume":"52","author":"Fleg","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications.","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tem.2016.09.005","article-title":"Inflammaging and \u2018Garb-aging\u2019.","volume":"28","author":"Franceschi","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaa1065","article-title":"Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.","volume":"7","author":"Fredman","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ajpath.2017.01.018","article-title":"Boosting inflammation resolution in atherosclerosis: the next frontier for therapy.","volume":"187","author":"Fredman","year":"2017","journal-title":"Am. J. Pathol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier.","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"B86","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2152\/jmi.56.88","article-title":"Saturated fatty acids and insulin resistance.","volume":"56","author":"Funaki","year":"2009","journal-title":"J. Med. Invest."},{"key":"B87","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1358836X9800300310","article-title":"Atherothrombosis: mechanisms and clinical therapeutic approaches.","volume":"3","author":"Fuster","year":"1998","journal-title":"Vasc. Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gheart.2011.08.002","article-title":"Summary of the institute of medicine report promoting cardiovascular health in the developing world.","volume":"6","author":"Fuster","year":"2011","journal-title":"Glob. Heart"},{"key":"B89","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/icb.2008.19","article-title":"Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses.","volume":"86","author":"Geissmann","year":"2008","journal-title":"Immunol. Cell Biol."},{"key":"B90","first-page":"380","article-title":"Lipoxins: novel anti-inflammatory therapeutics?","volume":"1","author":"Godson","year":"2000","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages.","volume":"164","author":"Godson","year":"2000","journal-title":"J. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.plefa.2017.08.009","article-title":"Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients.","volume":"125","author":"Goicoechea","year":"2017","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B93","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0735-1097(02)02065-X","article-title":"Coronary atherosclerosis in diabetes mellitus. A population-based autopsy study.","volume":"40","author":"Goraya","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/imr.12453","article-title":"Clearance of apoptotic neutrophils and resolution of inflammation.","volume":"273","author":"Greenlee-Wacker","year":"2016","journal-title":"Immunol. Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","article-title":"Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.","volume":"391","author":"Gregg","year":"2018","journal-title":"Lancet"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010.","volume":"370","author":"Gregg","year":"2014","journal-title":"New Engl. J. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0735-1097(02)02972-8","article-title":"Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus.","volume":"41","author":"Gresele","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.plefa.2005.05.009","article-title":"Lipoxins in the eye and their role in wound healing.","volume":"73","author":"Gronert","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B99","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.plefa.2005.05.012","article-title":"Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.","volume":"73","author":"Guilford","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B100","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/ars.2017.7299","article-title":"Epigenetics and immunometabolism in diabetes and aging.","volume":"29","author":"Guzik","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"B101","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/01.iae.0000247165.38655.bf","article-title":"Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.","volume":"26","author":"Haritoglou","year":"2006","journal-title":"Retina"},{"key":"B102","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1053\/j.ackd.2014.03.009","article-title":"Epidemiology and risk factors for diabetic kidney disease.","volume":"21","author":"Harjutsalo","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"B103","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1089\/jop.2010.0187","article-title":"Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.","volume":"27","author":"He","year":"2011","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/j.jid.2018.03.1498","article-title":"Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair.","volume":"138","author":"Hellmann","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1096\/fj.10-178657","article-title":"Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.","volume":"25","author":"Hellmann","year":"2011","journal-title":"FASEB J."},{"key":"B106","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease.","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1161\/ATVBAHA.113.303044","article-title":"Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice.","volume":"34","author":"Hewing","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.2353\/ajpath.2010.091082","article-title":"Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/mi.2016.33","article-title":"Lipoxin A4 activates ALX\/FPR2 receptor to regulate conjunctival goblet cell secretion.","volume":"10","author":"Hodges","year":"2017","journal-title":"Mucosal Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation.","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution.","volume":"180","author":"Hong","year":"2008","journal-title":"J. Immunol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1167\/iovs.10-5768","article-title":"TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.","volume":"52","author":"Huang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B113","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/oby.22103","article-title":"Dual CCR2\/5 antagonist attenuates obesity-induced insulin resistance by regulating macrophage recruitment and M1\/M2 status.","volume":"26","author":"Huh","year":"2018","journal-title":"Obesity"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135218","article-title":"LXR-mediated ABCA1 expression and function are modulated by high glucose and PRMT2.","volume":"10","author":"Hussein","year":"2015","journal-title":"PLoS One"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1172\/JCI84518","article-title":"CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability.","volume":"126","author":"Ivanov","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-017-0213-3","article-title":"Mechanism of worsening diabetic retinopathy with rapid lowering of blood glucose: the synergistic hypothesis.","volume":"17","author":"Jingi","year":"2017","journal-title":"BMC Endocrine Disord."},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes.","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition.","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B119","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/nep.12374","article-title":"Study of microRNA in diabetic nephropathy: isolation, quantification and biological function.","volume":"20","author":"Kantharidis","year":"2015","journal-title":"Nephrology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6809703","article-title":"The role of AGE\/RAGE signaling in diabetes-mediated vascular calcification.","volume":"2016","author":"Kay","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1046\/j.1523-1755.2003.00106.x","article-title":"Modification of the transcriptomic response to renal ischemia\/reperfusion injury by lipoxin analog.","volume":"64","author":"Kieran","year":"2003","journal-title":"Kidney Int."},{"key":"B122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"B123","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1517\/13543784.2012.681043","article-title":"Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.","volume":"21","author":"Kowluru","year":"2012","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"B124","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors.","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B125","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2337\/dc13-0985","article-title":"Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.","volume":"37","author":"Krolewski","year":"2014","journal-title":"Diabetes Care"},{"key":"B126","doi-asserted-by":"publisher","first-page":"49982","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages.","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/01.ATV.0000124105.39900.db","article-title":"Imatinib attenuates diabetes-associated atherosclerosis.","volume":"24","author":"Lassila","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"i89","DOI":"10.1093\/ndt\/gfw388","article-title":"What can target kidney fibrosis?","author":"Leaf","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"B129","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(12)61031-9","article-title":"Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.","volume":"380","author":"Lee","year":"2012","journal-title":"Lancet"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/416036","article-title":"BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets.","volume":"2012","author":"Lee","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1167\/iovs.14-15982","article-title":"Inhibition of corneal inflammation by the resolvin E1.","volume":"56","author":"Lee","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1681\/ASN.2009060615","article-title":"Distinct macrophage phenotypes contribute to kidney injury and repair.","volume":"22","author":"Lee","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1097\/01.ASN.0000015795.74094.91","article-title":"15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.","volume":"13","author":"Leonard","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution.","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.plefa.2010.09.002","article-title":"The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection.","volume":"84","author":"Levy","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention.","volume":"8","author":"Li","year":"2002","journal-title":"Nat. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/mi.2013.7","article-title":"Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion.","volume":"6","author":"Li","year":"2013","journal-title":"Mucosal Immunol."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.199570","article-title":"Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob\/ob mice and reversal by a fish oil diet.","volume":"105","author":"Li","year":"2009","journal-title":"Circ. Res."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis.","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"B140","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1442-9071.2000.00222.x","article-title":"Retinal neurodegeneration: early pathology in diabetes.","volume":"28","author":"Lieth","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis.","volume":"7","author":"Liu","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-\u03b2 (TGF-\u03b2)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation.","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B143","first-page":"997","article-title":"Extracellular matrix alterations in human corneas with bullous keratopathy.","volume":"37","author":"Ljubimov","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B144","doi-asserted-by":"publisher","first-page":"11779","DOI":"10.1073\/pnas.0403259101","article-title":"Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.","volume":"101","author":"Llodra","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1573399812666151016101622","article-title":"Chronic complications of diabetes mellitus: a mini review.","volume":"13","author":"Lotfy","year":"2017","journal-title":"Curr. Diabetes Rev."},{"key":"B146","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis.","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.bbrc.2018.04.134","article-title":"Reversion of aging-related DHEAS decline in mouse plasma alleviates aging-related glucose tolerance impairment by potentiation of glucose-stimulated insulin secretion of acute phase.","volume":"500","author":"Ma","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B148","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1096\/fj.10-159913","article-title":"FPR2\/ALX receptor expression and internalization are critical for lipoxin A(4) and annexin-derived peptide-stimulated phagocytosis.","volume":"24","author":"Maderna","year":"2010","journal-title":"FASEB J."},{"key":"B149","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/j.1476-5381.2009.00386.x","article-title":"Lipoxins: resolutionary road.","volume":"158","author":"Maderna","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes.","volume":"377","author":"Mann","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization.","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression.","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B153","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment.","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000prime Rep."},{"key":"B154","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease.","volume":"35","author":"Mas","year":"2016","journal-title":"Clin. Nutr."},{"key":"B155","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/01.ATV.15.4.431","article-title":"Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group.","volume":"15","author":"McGill","year":"1995","journal-title":"Arterioscler Thromb Vasc. Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1096\/fj.02-0416fje","article-title":"Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation.","volume":"16","author":"McMahon","year":"2002","journal-title":"FASEB J."},{"key":"B157","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/bj3490353","article-title":"Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency.","author":"Meininger","year":"2000","journal-title":"Biochem. J."},{"key":"B158","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1096\/fj.08-112201","article-title":"Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.","volume":"22","author":"Merched","year":"2008","journal-title":"FASEB J."},{"key":"B159","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0002-9440(10)63181-1","article-title":"Lipoxins inhibit Akt\/PKB activation and cell cycle progression in human mesangial cells.","volume":"164","author":"Mitchell","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.","volume":"13","author":"Mitchell","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance.","volume":"13","author":"Moore","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis.","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"B163","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1167\/iovs.02-1063","article-title":"The role of advanced glycation end products in retinal microvascular leukostasis.","volume":"44","author":"Moore","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B164","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation.","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B165","first-page":"154","article-title":"Novel translational model of resolving inflammation triggered by UV-killed","volume":"2","author":"Motwani","year":"2016","journal-title":"E. coli. J. Pathol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.1074\/jbc.274.9.5830","article-title":"Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells.","volume":"274","author":"Murphy","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"key":"B168","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejphar.2017.10.005","article-title":"Heterogeneity of atherosclerotic plaque macrophage origin, phenotype and functions: implications for treatment.","volume":"816","author":"Nagenborg","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B169","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"B170","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation.","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"B171","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1021\/jm060270d","article-title":"Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.","volume":"50","author":"O\u2019Sullivan","year":"2007","journal-title":"J. Med. Chem."},{"key":"B172","doi-asserted-by":"publisher","first-page":"L904","DOI":"10.1152\/ajplung.00370.2014","article-title":"Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.","volume":"308","author":"Orr","year":"2015","journal-title":"Am. J. Physiol. Lung. Cell. Mol. Physiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-3-319-64010-5_15","author":"Orban","year":"2018","journal-title":"Acute Complications of Diabetes. Metabolic Disorders and Critically Ill Patients"},{"key":"B174","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I.","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur. Heart J."},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6989453","article-title":"Complications of diabetes 2016.","volume":"2016","author":"Papatheodorou","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/187152806776383125","article-title":"Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.","volume":"5","author":"Parkinson","year":"2006","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"B177","doi-asserted-by":"publisher","first-page":"23S","DOI":"10.1016\/S0002-9149(98)90427-1","article-title":"The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.","volume":"82","author":"Pepine","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000327599","article-title":"Effect of bardoxolone methyl on kidney function in patients with T2D and stage 3b\u20134 CKD.","volume":"33","author":"Pergola","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.bmcl.2008.01.013","article-title":"Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.","volume":"18","author":"Petasis","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B180","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A(4) signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.","volume":"179","author":"Petri","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1900\/RDS.2015.12.87","article-title":"Diabetic kidney disease: a syndrome rather than a single disease.","volume":"12","author":"Piccoli","year":"2015","journal-title":"Rev. Diabetic Stud."},{"key":"B182","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1074\/jbc.M114.592352","article-title":"MicroRNA-181b regulates ALX\/FPR2 receptor expression and proresolution signaling in human macrophages.","volume":"290","author":"Pierdomenico","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1172\/JCI43802","article-title":"Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe\u2013\/\u2013 mice during disease regression.","volume":"121","author":"Potteaux","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B184","first-page":"339","article-title":"Diabetes-induced dysfunction of retinal Muller cells.","volume":"100","author":"Puro","year":"2002","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"B185","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/path.4050","article-title":"Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.","volume":"228","author":"Qu","year":"2012","journal-title":"J. Pathol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","article-title":"Advanced glycation end products in the pathogenesis of chronic kidney disease.","volume":"93","author":"Rabbani","year":"2018","journal-title":"Kidney Int."},{"key":"B187","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/MOL.0b013e32830d5f09","article-title":"Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis.","volume":"19","author":"Randolph","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/oby.2007.342","article-title":"Effect of obesity on high-density lipoprotein metabolism.","volume":"15","author":"Rashid","year":"2007","journal-title":"Obesity"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.","volume":"121","author":"Rayner","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B190","doi-asserted-by":"publisher","first-page":"541A","DOI":"10.1067\/mva.2001.115963","article-title":"Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E\u2013deficient mouse in a novel transplantation model.","volume":"34","author":"Reis","year":"2001","journal-title":"J. Vasc. Surg."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B192","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1\u03b2 by canakinumab and cardiovascular outcomes in patients with chronic kidney disease.","volume":"71","author":"Ridker","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ahj.2011.06.012","article-title":"Interleukin-1\u03b2 inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).","volume":"162","author":"Ridker","year":"2011","journal-title":"Am. Heart. J."},{"key":"B194","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0002-9440(10)62043-3","article-title":"Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.","volume":"167","author":"Rodgers","year":"2005","journal-title":"Am. J. Pathol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/hc4501.098952","article-title":"Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content.","volume":"104","author":"Rong","year":"2001","journal-title":"Circulation"},{"key":"B196","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1155\/MI\/2006\/60285","article-title":"Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1.","volume":"2006","author":"Rossi","year":"2006","journal-title":"Mediat. Inflamm."},{"key":"B198","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41581-018-0011-9","article-title":"Subclassification of diabetes based on quantitative traits.","volume":"14","author":"Rossing","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"B199","first-page":"258","article-title":"Fibronectin overexpression in retinal microvessels of patients with diabetes.","volume":"37","author":"Roy","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI116979","article-title":"Increased expression of basement membrane collagen in human diabetic retinopathy.","volume":"93","author":"Roy","year":"1994","journal-title":"J. Clin. Invest."},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040942","article-title":"Role of Inflammation in Diabetic Retinopathy.","volume":"19","author":"Rubsam","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/01.CON.0000455884.29545.d2","article-title":"Diabetic neuropathies.","volume":"20","author":"Russell","year":"2014","journal-title":"Continuum"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00125-014-3202-3","article-title":"Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.","volume":"57","author":"Sandholm","year":"2014","journal-title":"Diabetologia"},{"key":"B204","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","article-title":"Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"B205","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 Inflammasome: a sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"B206","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","article-title":"Inflammation as common soil of the multifactorial diseases.","volume":"10","author":"Scrivo","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"B207","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/0005-2760(89)90264-6","article-title":"On the relationship between leukotriene and lipoxin production by human neutrophils: evidence for differential metabolism of 15-HETE and 5-HETE.","volume":"1004","author":"Serhan","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"B208","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B209","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Novel pro-resolving lipid mediators in inflammation are leads for resolution physiology.","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"B210","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1096\/fj.06-7227rev","article-title":"Resolution of inflammation: state of the art, definitions and terms.","volume":"21","author":"Serhan","year":"2007","journal-title":"FASEB J."},{"key":"B211","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution.","volume":"27","author":"Serhan","year":"2015","journal-title":"Semin. Immunol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.","volume":"192","author":"Serhan","year":"2000","journal-title":"J. Exp. Med."},{"key":"B213","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1073\/pnas.81.17.5335","article-title":"Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes.","volume":"81","author":"Serhan","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.","volume":"196","author":"Serhan","year":"2002","journal-title":"J. Exp. Med."},{"key":"B215","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1021\/cr100396c","article-title":"Resolvins and protectins in inflammation resolution.","volume":"111","author":"Serhan","year":"2011","journal-title":"Chem. Rev."},{"key":"B216","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI114503","article-title":"Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro.","volume":"85","author":"Serhan","year":"1990","journal-title":"J. Clin. Invest."},{"key":"B217","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev.pathmechdis.3.121806.151409","article-title":"Anti-inflammatory and proresolving lipid mediators.","volume":"3","author":"Serhan","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/318621","article-title":"Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis.","volume":"2012","author":"Settimio","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"B220","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2337\/diacare.28.2.445","article-title":"Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.","volume":"28","author":"Sfikakis","year":"2005","journal-title":"Diabetes Care"},{"key":"B221","first-page":"6708","article-title":"Lipoxin A4 promotes ABCA1 expression and cholesterol efflux through the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells.","volume":"8","author":"Sha","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1875870","article-title":"Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy.","volume":"2018","author":"Sifuentes-Franco","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2337\/dc11-2114","article-title":"Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.","volume":"35","author":"Singh","year":"2012","journal-title":"Diabetes Care"},{"key":"B224","first-page":"296","article-title":"Diabetes mellitus and uveitis: a longitudinal study.","volume":"50","author":"Sivaraj","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B225","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2013.10.006","article-title":"Resolvins, specialized pro-resolving lipid mediators and their potential roles in metabolic diseases.","volume":"19","author":"Spite","year":"2014","journal-title":"Cell Metab."},{"key":"B226","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1167\/iovs.17-22736","article-title":"Corneal and retinal neuronal degeneration in early stages of diabetic retinopathy.","volume":"58","author":"Srinivasan","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1046\/j.1523-1755.2000.00997.x","article-title":"Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation.","volume":"57","author":"Strutz","year":"2000","journal-title":"Kidney Int."},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000400","article-title":"Assesment of conjunctival microangiopathy in a patient with diabetes mellitus using the retinal function imager.","volume":"6","author":"Stuebiger","year":"2015","journal-title":"J. Clin. Exp. Ophthalmol."},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2629","article-title":"Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.","volume":"18","author":"Sugimoto","year":"2012","journal-title":"Nat. Med."},{"key":"B230","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plefa.2009.09.004","article-title":"Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs.","volume":"81","author":"Sun","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084063","article-title":"Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney.","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"B232","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation.","volume":"282","author":"Sun","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.14","article-title":"Potential approaches to reverse or repair renal fibrosis.","volume":"10","author":"Tampe","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"B234","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.4049\/jimmunol.1400942","article-title":"Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.","volume":"193","author":"Tang","year":"2014","journal-title":"J. Immunol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000346950","article-title":"The extinguished beacon of bardoxolone: not a monday morning quarterback story.","volume":"37","author":"Tayek","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2337\/db15-1313","article-title":"Genome-wide association studies identify genetic loci associated with albuminuria in diabetes.","volume":"65","author":"Teumer","year":"2015","journal-title":"Diabetes"},{"key":"B237","article-title":"Untangling the complications of diabetes.","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"B238","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease.","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"B239","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0209115","article-title":"Mechanisms and consequences of efferocytosis in advanced atherosclerosis.","volume":"86","author":"Thorp","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"B240","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1167\/iovs.08-3146","article-title":"Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions.","volume":"50","author":"Tian","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1523-1755.2005.00606.x","article-title":"Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status.","volume":"68","author":"Tinckam","year":"2005","journal-title":"Kidney Int."},{"key":"B242","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.2337\/db15-0254","article-title":"Genetic evidence for a causal role of obesity in diabetic kidney disease.","volume":"64","author":"Todd","year":"2015","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B243","doi-asserted-by":"publisher","first-page":"636","DOI":"10.4239\/wjd.v5.i5.636","article-title":"Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.","volume":"5","author":"Tomkin","year":"2014","journal-title":"World J. Diabetes"},{"key":"B244","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.2337\/diabetes.54.suppl_2.S40","article-title":"Type 1 and type 2 diabetes. What Do They Have in Common?","author":"Tuomi","year":"2005","journal-title":"Diabetes"},{"key":"B245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0158-z","article-title":"The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.","volume":"13","author":"Vallejo","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/db17-0914","article-title":"A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes.","volume":"67","author":"van Zuydam","year":"2018","journal-title":"Diabetes"},{"key":"B248","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1155\/EDR.2000.221","article-title":"Alterations in nitric oxide activity and sensitivity in early streptozotocin-induced diabetes depend on arteriolar size.","volume":"1","author":"vanDam","year":"2000","journal-title":"Int. J. Exp. Diabetes Res."},{"key":"B249","first-page":"s3","article-title":"The global burden of diabetes and its complications: an emerging pandemic.","author":"van Dieren","year":"2010","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD.","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1681\/ASN.2015111230","article-title":"Anti-TGF-beta1 antibody therapy in patients with diabetic nephropathy.","volume":"28","author":"Voelker","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1172\/JCI2237","article-title":"Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat.","volume":"102","author":"Vukicevic","year":"1998","journal-title":"J. Clin. Invest."},{"key":"B253","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ki.2013.372","article-title":"Transforming growth factor-beta1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.","volume":"85","author":"Wang","year":"2014","journal-title":"Kidney Int."},{"key":"B254","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000455818","article-title":"The role of fish oil in inflammatory eye diseases.","volume":"2","author":"Wang","year":"2017","journal-title":"Biomed. Hub."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1161\/CIRCRESAHA.117.311984","article-title":"CANTOS Trial validates the inflammatory pathogenesis of atherosclerosis: setting the stage for a new chapter in therapeutic targeting.","volume":"121","author":"Weber","year":"2017","journal-title":"Circ. Res."},{"key":"B256","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/db11-0944","article-title":"miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets.","volume":"61","author":"Wijesekara","year":"2012","journal-title":"Diabetes"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030.","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"B258","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1161\/01.ATV.0000174795.62387.d3","article-title":"Lipoprotein retention\u2013and clues for atheroma regression.","volume":"25","author":"Williams","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1160\/TH11-05-0320","article-title":"Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.","volume":"106","author":"Wolfs","year":"2011","journal-title":"Thromb. Haemost."},{"key":"B261","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1365-2133.2012.11177.x","article-title":"Efficacy and safety of 15(R\/S)-methyl-lipoxin A4 in topical treatment of infantile eczema.","volume":"168","author":"Wu","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"B262","first-page":"225","article-title":"Protective effects of 15-methyl-lipoxin A4 on mesangioproliferative nephritis in rats.","volume":"8","author":"Wu","year":"2006","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B263","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2353\/ajpath.2009.080671","article-title":"Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis.","volume":"174","author":"Wu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"B264","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.plefa.2006.12.006","article-title":"Signal transduction involved in protective effects of 15(R\/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.","volume":"76","author":"Wu","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/752387","article-title":"Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.","volume":"2014","author":"Wu","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.107","article-title":"Insights into kidney diseases from genome-wide association studies.","volume":"12","author":"Wuttke","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B267","author":"Xu","year":"2014","journal-title":"Pathophysiology and Pathogenesis of Diabetic Retinopathy."},{"key":"B268","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm0106-62","article-title":"Epidemiologic and economic consequences of the global epidemics of obesity and diabetes.","volume":"12","author":"Yach","year":"2006","journal-title":"Nat. Med."},{"key":"B269","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1093\/ndt\/gfs381","article-title":"Inhibitors\/antagonists of TGF-\u03b2 system in kidney fibrosis.","volume":"27","author":"Yanagita","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B270","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy.","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"B271","first-page":"242","article-title":"Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: possible involvement of NLRP3 inflammasome and NF-kappaB signaling pathway.","volume":"23","author":"Yin","year":"2017","journal-title":"Mol. Vis."},{"key":"B272","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1189\/jlb.0302117","article-title":"Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization.","volume":"73","author":"Yoshida","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000161","article-title":"Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth.","volume":"4","author":"You","year":"2016","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"B274","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/ki.1995.312","article-title":"Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity.","volume":"48","author":"Young","year":"1995","journal-title":"Kidney Int."},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00086","article-title":"Mechanisms and consequences of defective efferocytosis in atherosclerosis.","volume":"4","author":"Yurdagul","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"B276","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1681\/ASN.2010060616","article-title":"Resolved: EMT produces fibroblasts in the kidney.","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B277","doi-asserted-by":"publisher","first-page":"F1375","DOI":"10.1152\/ajprenal.00020.2013","article-title":"Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS.","volume":"304","author":"Zhang","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B278","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.116.021894","article-title":"Resolvin D2 enhances post-ischemic revascularization while resolving inflammation.","volume":"134","author":"Zhang","year":"2016","journal-title":"Circulation"},{"key":"B279","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4103\/0366-6999.180517","article-title":"Resolvin D1 protects lipopolysaccharide-induced acute kidney injury by down-regulating nuclear factor-kappa b signal and inhibiting Apoptosis.","volume":"129","author":"Zhao","year":"2016","journal-title":"Chin. Med. J."},{"key":"B280","doi-asserted-by":"publisher","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic.","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T08:43:11Z","timestamp":1545208991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":280,"alternative-id":["10.3389\/fphar.2018.01488"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01488","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"article-number":"1488"}}